Cell Therapies: US FDA Asked To Clarify Development Standards For Early-Phase Trials

 
• By Sue Sutter
  
3d illustration of immune system T cells attacking cancer cells (CAR T-cell therapy) - Illustration
The US FDA is being urged to clarify early clincial development standards for CAR-T. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies